Steroid responsive encephalopathy in cerebral amyloid angiopathy: A case report and review of evidence for immunosuppressive treatment

Journal of Neuroinflammation

Volumn 7, Issue , 2010, Pages

  Kloppenborg, Raoul P ^a   Richard, Edo ^a   Sprengers, Marieke E S ^a   Troost, Dirk ^a   Eikelenboom, Piet ^a   Nederkoorn, Paul J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; DEXAMETHASONE; STEROID;

AGED; APATHY; ARTICLE; BRAIN BIOPSY; CASE REPORT; DISORIENTATION; FOLLOW UP; FRONTAL LOBE; GAIT DISORDER; GLIOSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOENCEPHALOPATHY; MALE; MUSCLE HYPERTONIA; NERVOUS SYSTEM INFLAMMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN CEREBROSPINAL FLUID LEVEL; SEIZURE; SOMNOLENCE; VASCULAR AMYLOIDOSIS; WHITE MATTER; METHODOLOGY; PATHOLOGY; REVIEW;

AGED; CEREBRAL AMYLOID ANGIOPATHY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; STEROIDS;

EID: 77951176094     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-7-18     Document Type: Article

References (23)

1. Yamada M, Tsukagoshi H, Otomo E, Hayakawa M. Cerebral amyloid angiopathy in the aged. J Neurol 1987, 234:371-6. 10.1007/BF00314080, 3655840.
2. Gilbert JJ, Vinters HV. Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage. Stroke 1983, 14:915-23.
3. Greenberg SM, Vonsattel JPG, Stakes JW, Gruber M, Finklestein SP. The clinical spectrum of cerebral amyloid angiopathy: Presentations without lobar hemorrhage. Neurology 1993, 43:2073-2079.
4. Osumi KA, Tien RD, Felsberg GJ, Rosenbloom M. Cerebral amyloid angiopathy presenting as a brain mass. Am J Neuroradiol 1995, 16:911-915.
5. Safriel Y, Sze G, Westmark K, Baehring J. MR spectroscopy in the diagnosis of cerebral amyloid angiopathy presenting as a brain tumor. Am J Neuroradiol 2004, 25:1705-8.
6. Kinnecom C, Lev MH, Wendell L, Smith EE, Rosand J, Frosch MP, Greenberg SM. Course of cerebral amyloid angiopathy-related inflammation. Neurology 2007, 68:1411-6. 10.1212/01.wnl.0000260066.98681.2e, 17452586.
7. Aisen PS. The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease. Lancet Neurol 2002, 1:279-84. 10.1016/S1474-4422(02)00133-3, 12849425.
8. McHugh JC, Ryan AM, Lynch T, Dempsey E, Stack J, Farrell MA, Kelly PJ. Steroid-responsive recurrent encephalopathy in a patient with cerebral amyloid angiopathy. Cerebrovasc Dis 2007, 23:66-9. 10.1159/000097030, 17108675.
9. Ginsberg L, Geddes J, Valentine A. Amyloid angiopathy and granulomatous angiitis of the central nervous system: a case responding to corticosteroid treatment. J Neurol 1988, 235:438-40. 10.1007/BF00314491, 3221250.
10. Mandybur TI, Balko G. Cerebral amyloid angiopathy with granulomatous angiitis ameliorated by steroid-cytoxan treatment. Clin Neuropharmacol 1992, 15:241-7. 10.1097/00002826-199206000-00005, 1394245.
11. Silbert PL, Bartleson JD, Miller GM, Parisi JE, Goldman MS, Meyer FB. Cortical petechial hemorrhage, leukoencephalopathy, and subacute dementia associated with seizures due to cerebral amyloid angiopathy. Mayo Clin Proc 1995, 70:477-80. 10.4065/70.5.477, 7731259.
12. Fountain NB, Eberhard DA. Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy: Report of two cases and review of the literature. Neurology 1996, 46:190-197.
13. Ortiz O, Reed L. Cerebral amyloid angiopathy presenting as a nonhemorrhagic, infiltrating mass. Neuroradiology 1996, 38:449-52.
14. Masson C, Hénin D, Colombani JM, Dehen H. A case of cerebral giant-cell angiitis associated with cerebral amyloid angiopathy. Favorable evolution with corticosteroid therapy. Rev Neurol (Paris) 1998, 154:695-8.
15. Fountain NB, Lopes MB. Control of primary angiitis of the CNS associated with cerebral amyloid angiopathy by cyclophosphamide alone. Neurology 1999, 52:660-2.
16. Streichenberger N, Girard-Madoux P, Verejan I, Pialat J, Vital C, Kopp N. Giant cell angiitis of the central nervous system with amyloid angiopathy. A case report and review of the literature. Clin Exp Pathol 1999, 47:311-7.
17. Hoshi K, Yoshida K, Nakamura A, Tada T, Tamaoka A, Ikeda S. Cessation of cerebral hemorrhage recurrence associated with corticosteroid treatment in a patient with cerebral amyloid angiopathy. Amyloid 2000, 7:284-8. 10.3109/13506120009146443, 11132098.
18. Schwab P, Lidov HGW, Schwartz RB, Anderson RJ. Cerebral amyloid angiopathy associated with primary angiitis of the central nervous system: report of 2 cases and review of the literature. Arthr Reum 2003, 49:421-427.
19. Oh U, Gupta R, Krakauer JW, Khandji AG, Chin SS, Elkind MS. Reversible leukoencephalopathy associated with cerebral amyloid angiopathy. Neurology 2004, 62:494-7.
20. Scolding NJ, Joseph F, Kirby PA, Mazanti I, Gray F, Mikol J, Ellison D, Hilton DA, Williams TL, MacKenzie JM, Xuereb JH, Love S. Aβ-relAted angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 2005, 128:500-15. 10.1093/brain/awh379, 15659428.
21. Machida K, Tojo K, Naito KS, Gono T, Nakata Y, Ikeda S. Cortical petechial hemorrhage, subarachnoid hemorrhage and corticosteroid-responsive leukoencephalopathy in a patient with cerebral amyloid angiopathy. Amyloid 2008, 15:60-4. 10.1080/13506120701815589, 18266123.
22. Salvarani C, Brown RD, Calamia KT, Christianson TJ, Huston J, Meschia JF, Giannini C, Miller DV, Hunder GG. Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy. Rheumatology 2008, 47:1671-7. 10.1093/rheumatology/ken328, 18753193.
23. Previti ML, Zhang W, van Nostrand WE. Dexamethason diminishes the pro-inflammatory and cytotoxic effects of β-protein in cerebrovascular smooth muscle cells. J Neuroinflammation 2006, 3:18. 10.1186/1742-2094-3-18, 1557842, 16887032.